Riskpilot← Back to searchSign inGet full accessDawn Health A/S
A/SActiveCVR 37683264Sundkaj 153, 1. thComputer programming activities · NACE 6210Est. 201699 employeeswww.dawnhealth.com
Revenue 2025
DKK 21,2M
-21% vs 2024
EBITDA margin
-325.0%
-58% vs 2024
Equity ratio
76.6%
Financial strength
Net profit 2025
DKK -78,2M
-50% vs 2024
| Revenue | DKK 21,2M | -21% |
| EBITDA | DKK -68,9M | -58% |
| Net profit | DKK -78,2M | -50% |
| Total assets | DKK 80,1M | +19% |
| Equity | DKK 61,3M | +14% |
| Employees | 99 | — |
Legal name
Dawn Health A/S
CVR number
37683264
Legal form
Aktieselskab
NACE code
6210 · Computer programming activities
Founded
1. maj 2016
Share capital
DKK 404.211
Employees
99 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden og én direktør i forening
Company purpose
Selskabets formål er at drive virksomhed med udvikling, rådgivning og salg af software samt hermed forbundet virksomhed
Address
Sundkaj 153, 1. th
Phone
+4531333156
Email
alh@dawnhealth.com
Website
www.dawnhealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27.486 | 47.157 | 51.562 | 26.783 | 21.206 |
| Staff expenses | -23.983 | -57.521 | -70.899 | -70.408 | -90.118 |
| EBITDA | 3.502 | -10.363 | -19.337 | -43.626 | -68.912 |
| Depreciation & amort. | -326 | -542 | -5.340 | -8.284 | -10.210 |
| EBIT | 3.176 | -10.905 | -24.677 | -51.909 | -79.122 |
| Net financials | -496 | -7.444 | -7.248 | -3.614 | -2.280 |
| Profit before tax | 2.680 | -16.559 | -29.581 | -55.413 | -81.402 |
| Tax | 813 | -4.756 | -4.294 | -3.196 | -3.185 |
| Net profit | 1.867 | -11.803 | -25.287 | -52.217 | -78.217 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 139.855 | 137.478 | 111.276 | 67.269 | 80.096 |
| Equity | 8.055 | -3.748 | -29.035 | 53.750 | 61.332 |
| Long-term debt | 0 | 129.078 | 128.250 | 1.322 | 0 |
| Short-term debt | 131.800 | 11.229 | 12.061 | 12.197 | 18.764 |
| Total debt | 131.800 | 140.307 | 140.311 | 13.519 | 18.764 |
EBITDA margin
-325.0%
This company
15.8%
Market median
-2157% vs market
20212025
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
-127.5%
This company
18.4%
Market median
-793% vs market
20212025
Net profit margin
-368.8%
This company
8.1%
Market median
-4653% vs market
20212025
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Management | Management | 2023 |
| Former (1) | ||
DG Chief Executive Officer | Chief Executive Officer | 2017 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2021 | |
| Chairman | 2026 | |
| Board of Directors | 2021 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Former (8) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2021 – 2026 | |
| Chairman | 2016 – 2019 | |
| Chairman | 2026 – 2026 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2019 – 2021 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AUGUSTINUS FONDENCHR. AUGUSTINUS FABRIKKER AKTIESELSKABDawn Holding ApS
Dawn Health A/S (this company)Board members of Dawn Health A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Mandix Hansen | Management | 0 companies |
| Daniel Gewecke Daugaard-Jensen | Chief Executive Officer | 0 companies |
| John Rubek Lauritsen | Board of Directors | 0 companies |
| Chresten Plinius | Board of Directors | 0 companies |
| Søren Wulf Eskildsen | Board of Directors | 0 companies |
| Anne-Marie Levy Rasmussen | Chairman | 0 companies |
| Lars Marcher | Chairman | 0 companies |
| Johan Blach Petersen | Chairman | 0 companies |
| Mads Lacoppidan | Board of Directors | 0 companies |
| Jørn Larsen | Chairman | 0 companies |
| Nadia Catherine Carlsten | Board of Directors | 0 companies |
| Martin Cappelen Arup | Board of Directors | 0 companies |
| Jesper Grankær Carøe | Chairman | 0 companies |
| Arne Ansgar Kirchheim | Board of Directors | 0 companies |
| Thomas Jannik Galbo | Board of Directors | 0 companies |